BSG and ovarian carcinoma: Furthermore, higher levels of EMMPRIN expression were demonstrated to be correlated with more advanced clinical features and to predict diminished survival in patients with pancreatobiliary adenocarcinomas and ovarian carcinoma [36], [37].